SUNNYVALE, Calif. , Feb. 5, 2020 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) announced today that two new studies demonstrate the benefits of the TomoTherapy ® System  in the treatment of advanced rectal cancer. Radiotherapy, with or without chemotherapy, followed by surgery […]

SUNNYVALE, Calif. , Jan. 28, 2020 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported its financial results for the second quarter of fiscal 2020 ended December 31, 2019 . Recent Company Highlights Gross orders of $98.6 million , including 11 orders from China Net orders of $89.9 […]

SUNNYVALE, Calif. , Jan. 16, 2020 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) will report results for its second quarter ended December 31, 2019 on Tuesday, January 28, 2020 after the market close. Management will host a conference call to review the results at 1:30 p.m. PT / 4:30 p.m. […]

Company to present on Wednesday, January 15, 2020 at 10 am PT / 1 pm ET SUNNYVALE, Calif. , Jan. 13, 2020 /PRNewswire/ --  Accuray Incorporated (Nasdaq: ARAY) will be discussing its business and revenue growth expectations for the next three fiscal years at the JP Morgan Healthcare […]

SUNNYVALE, Calif. , Jan. 8, 2020 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) announced today data from a prospective study which showed that at five years, stereotactic body radiation therapy (SBRT) administered with the CyberKnife ® System provided excellent disease control with […]